Veeva Summit: Why Takeda is taking ownership of its technology
Global biopharmaceutical company Takeda is working to modernize its operations in order to better serve clinical trial sites, patients and sponsor outcomes.
Archives for September 14, 2023
Vaxess announces $9 million in funding for mRNA vaccine patch
Vaxess Technologies, a life sciences company developing a shelf-stable vaccine patch with potential for self-application, has announced an additional $9 million in venture capital funding, with investors including RA Capital, The Engine, and GHIC, and...
Celltrion marks decade of biosimilar innovation in Europe with new campaign
Celltrion Healthcare has launched a new campaign to celebrate a decade of biosimilar innovation in Europe.